ADVERTISEMENT

Aggressive and delusional about his alien origins, but refusing treatment

Current Psychiatry. 2014 June;13(6):61-64, A
Author and Disclosure Information

Mr. C, age 23, has persistent hallucinations and delusions, despite 4 trials of antipsychotic medication. He refuses clozapine because of the required weekly blood draws. What would you do next?

The authors’ observations
At times we have instituted all of the meth­ods noted in Table 2. We have most often used dissolving tablets and plasma monitoring.

OUTCOME Improvement, transfer
Mr. C gradually improves over 6 months. The voices, delusions, and aggression resolve. He remains mildly disorganized and has poor insight, with unrealistic goals. Approximately 3 years after admission and 1 year after clo­zapine was initiated, Mr. C is transferred to a minimum-security facility.

The authors’ observations
Overall, our experience has been success­ful with the approach we have described. Patients often do not resist the treatment plan once they see our commitment to their well-being. When they do resist, it has been only for 1 to 3 doses of medica­tion, and 1 or 2 blood draws. Of 6 recent cases under this protocol, we have dis­charged 3; 1 is approaching discharge; 1 has had minimal improvement to date; and 1 required discontinuation because of neutropenia. We recommend considering involuntary clozapine therapy for refractory patients who have a poor prognosis.

Bottom Line
Clozapine is an underutilized treatment for refractory schizophrenia, often because of patient refusal. In a case presentation format we review the barriers to clozapine therapy. We discuss clinical and legal issues for administering clozapine to an unwilling patient.

Related Resources
• Hill M, Freundenrich O. Clozapine: key discussion points for pre­scribers. Clin Schizophr Relat Psychoses. 2013;6(4):177-185.
• Nielsen J, Correll C, Manu P, et al. Termination of clozapine treat­ment due to medical reasons: when is it warranted and how can it be avoided? J Clin Psychiatry. 2013;74(6):603-613.


Drug Brand Names
Aripiprazole • Abilify                            
Polyethylene glycol • MiraLax
Clozapine • Clozaril, FazaClo                
ropranolol • Inderal LA
Desmopressin • DDAVP                     
Quetiapine • Seroquel
Divalproex sodium • Depakote             
Risperidone • Risperdal
Haloperidol • Haldol                            
Sertraline • Zoloft
Lithium • Eskalith, Lithobid   
Terazosin • Hytrin
Olanzapine • Zyprexa            
Topiramate • Topamax